Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07076368 · ClinicalTrials.gov registry record · Phase 3
Ropivacaine and Fentanyl for Labor Epidural Initiation
A Phase 3 study of Pregnancy and Labor Analgesia, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07076368: Recruiting Phase 3 study of Pregnancy and Labor Analgesia, sponsored by University of California, San Francisco.
NCT07076368 is a Phase 3 study of Pregnancy and Labor Analgesia that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 50 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07076368, a Phase 3 study of Pregnancy and Labor Analgesia, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to determine the most effective dose of medicine to use to initially provide effective pain relief within the first 30 minutes of receiving an epidural for pain labor during labor. The study team will also study any side effects related to the epidural medication and patients' satisfaction with the quality of pain relief after receiving the epidural.
Primary Outcome
Numerical pain score using a discrete range from 0 (no pain) to 10 (most severe pain).
Conditions Studied
Interventions
- DRUG Ropivacaine + Fentanyl
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-10-24 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 3 |
What NCT07076368 shows while recruiting
NCT07076368 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine + Fentanyl is the first listed.
NCT07076368 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07076368 about?
NCT07076368 is a clinical study titled "Ropivacaine and Fentanyl for Labor Epidural Initiation". This study is being done to determine the most effective dose of medicine to use to initially provide effective pain relief within the first 30 minutes of receiving an epidural for pain labor during labor. The study team will also study any side effects related to the epidural medication and patient...
What is the current status of trial NCT07076368?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2025-10-24. Estimated completion is 2026-07-31.
What conditions does trial NCT07076368 study?
This clinical trial studies the following conditions: Pregnancy, Labor Analgesia, Labor and Delivery.
What interventions are being tested in trial NCT07076368?
The interventions under investigation include: Ropivacaine + Fentanyl (DRUG).
Who is sponsoring clinical trial NCT07076368?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07076368 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07076368's enrollment target sits among peer trials
50 152nd of 191 higher than 34 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Different Medications to Induce Labor
RECRUITING · Phase 3
-
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
RECRUITING · Phase 3
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
COMPLETED · Phase 3
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
COMPLETED · Phase 3
-
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
COMPLETED · Phase 3
-
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI